{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:22:11Z","timestamp":1779268931684,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T00:00:00Z","timestamp":1443052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s40261-015-0334-2","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T06:38:55Z","timestamp":1443076735000},"page":"743-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploratory Study of Total and Free Prednisolone Plasma Exposure and Cushingoid Appearance, Quality of Life and Biochemical Toxicity in Adult Male Kidney Transplant Recipients"],"prefix":"10.1007","volume":"35","author":[{"given":"Troels K.","family":"Bergmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Isbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remo","family":"Ostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"Barraclough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott B.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett C.","family":"McWhinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warrick J.","family":"Inder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E.","family":"Staatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,24]]},"reference":[{"key":"334_CR1","unstructured":"USA Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. 2011 annual report. http:\/\/optn.transplant.hrsa.gov . Accessed 5 May 2014."},{"issue":"1","key":"334_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, Keller F, Rasche FM, H\u00e4ussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61\u201398.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"334_CR3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jcem-38-3-407","volume":"38","author":"M Kozower","year":"1974","unstructured":"Kozower M, Veatch L, Kaplan MM. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab. 1974;38(3):407\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"334_CR4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40262-012-0007-8","volume":"51","author":"TK Bergmann","year":"2012","unstructured":"Bergmann TK, Barraclough KA, Lee KJ, Staatz CE. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation. Clin Pharmacokinet. 2012;51(11):711\u201341.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"334_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2125.1986.tb05173.x","volume":"21","author":"FJ Frey","year":"1986","unstructured":"Frey FJ, Ruegsegger MK, Frey BM. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone. Br J Clin Pharmacol. 1986;21(2):183\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"334_CR6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.healun.2005.11.460","volume":"25","author":"JM Morton","year":"2006","unstructured":"Morton JM, Williamson S, Kear LM, McWhinney BC, Potter J, Glanville AR. Therapeutic drug monitoring of prednisolone after lung transplantation. J Heart Lung Transplant. 2006;25(5):557\u201363.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"334_CR7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00007691-200408000-00011","volume":"26","author":"JM Potter","year":"2004","unstructured":"Potter JM, McWhinney BC, Sampson L, Hickman PE. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population. Ther Drug Monit. 2004;26(4):408\u201314.","journal-title":"Ther Drug Monit"},{"issue":"11","key":"334_CR8","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1432-2277.2012.01553.x","volume":"25","author":"KA Barraclough","year":"2012","unstructured":"Barraclough KA, Staatz CE, Johnson DW, Lee KJ, McWhinney BC, Ungerer JP, et al. Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week. Transpl Int. 2012;25(11):1182\u201393.","journal-title":"Transpl Int"},{"issue":"11","key":"334_CR9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/106002808201601109","volume":"16","author":"LZ Benet","year":"1982","unstructured":"Benet LZ, Frey FJ, Amend WJ Jr, Lozada F, Frey BM. Endogenous and exogenous glucocorticoids in cushingoid patients. Drug Intell Clin Pharm. 1982;16(11):863\u20138.","journal-title":"Drug Intell Clin Pharm."},{"issue":"2","key":"334_CR10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.1985.31","volume":"27","author":"H Bergrem","year":"1985","unstructured":"Bergrem H, Jervell J, Flatmark A. Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients. Kidney Int. 1985;27(2):459\u201364.","journal-title":"Kidney Int"},{"issue":"3","key":"334_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00627926","volume":"21","author":"FJ Frey","year":"1981","unstructured":"Frey FJ, Amend WJ, Lozada F, Frey BM, Holford NH, Benet LZ. Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients. Eur J Clin Pharmacol. 1981;21(3):235\u201342.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"334_CR12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1210\/jcem-51-3-561","volume":"51","author":"JG Gambertoglio","year":"1980","unstructured":"Gambertoglio JG, Vincenti F, Feduska NJ, Birnbaum J, Salvatierra O Jr, Amend WJ Jr. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients. J Clin Endocrinol Metab. 1980;51(3):561\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8374","key":"334_CR13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(84)91778-1","volume":"1","author":"L Ost","year":"1984","unstructured":"Ost L. Effects of cyclosporin on prednisolone metabolism. Lancet. 1984;1(8374):451.","journal-title":"Lancet"},{"issue":"5","key":"334_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/FTD.0b013e318187bb2f","volume":"30","author":"HA Bergrem","year":"2008","unstructured":"Bergrem HA, Bergrem H, Hartmann A, Hjelmesaeth J, Jenssen T. Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation. Ther Drug Monit. 2008;30(5):583\u201390.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"334_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01060885","volume":"9","author":"JQ Rose","year":"1981","unstructured":"Rose JQ, Yurchak AM, Jusko WJ. Dose dependent pharmacokinetics of prednisone and prednisolone in man. J Pharmacokinet Biopharm. 1981;9(4):389\u2013417.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"28","key":"334_CR16","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.jchromb.2010.08.044","volume":"878","author":"BC McWhinney","year":"2010","unstructured":"McWhinney BC, Briscoe SE, Ungerer JP, Pretorius CJ. Measurement of cortisol, cortisone, prednisolone, dexamethasone and 11-deoxycortisol with ultra high performance liquid chromatography-tandem mass spectrometry: application for plasma, plasma ultrafiltrate, urine and saliva in a routine laboratory. J Chromatogr B Anal Technol Biomed Life Sci. 2010;878(28):2863\u20139.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci."},{"issue":"3","key":"334_CR17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40261-013-0162-1","volume":"34","author":"TK Bergmann","year":"2014","unstructured":"Bergmann TK, Isbel NM, Barraclough KA, Campbell SB, McWhinney BC, Staatz CE. Comparison of the influence of cyclosporine and tacrolimus on the pharmacokinetics of prednisolone in adult male kidney transplant recipients. Clin Drug Investig. 2014;34(3):183\u20138.","journal-title":"Clin Drug Investig"},{"key":"334_CR18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-011-1071-y","volume":"67","author":"KA Barraclough","year":"2011","unstructured":"Barraclough KA, Isbel NM, McWhinney BC, Ungerer JP, Medley G, Johnson DW, et al. Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients. Eur J Clin Pharmacol. 2011;67:1243\u201352.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"334_CR19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"issue":"7351","key":"334_CR20","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/bmj.324.7351.1417","volume":"324","author":"A Garratt","year":"2002","unstructured":"Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002;324(7351):1417.","journal-title":"BMJ"},{"issue":"5","key":"334_CR21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0762","volume":"158","author":"SM Webb","year":"2008","unstructured":"Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, et al. Evaluation of health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire. Eur J Endocrinol. 2008;158(5):623\u201330.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"334_CR22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000012396","volume":"69","author":"N Sonino","year":"2000","unstructured":"Sonino N, Boscaro M, Fallo F, Fava GA. A clinical index for rating severity in Cushing\u2019s syndrome. Psychother Psychosom. 2000;69(4):216\u201320.","journal-title":"Psychother Psychosom"},{"key":"334_CR23","doi-asserted-by":"crossref","first-page":"e4928","DOI":"10.1136\/bmj.e4928","volume":"345","author":"L Fardet","year":"2012","unstructured":"Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing\u2019s syndrome: cohort study. BMJ. 2012;345:e4928.","journal-title":"BMJ"},{"issue":"11","key":"334_CR24","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrendo.2013.183","volume":"9","author":"RA Quax","year":"2013","unstructured":"Quax RA, Manenschijn L, Koper JW, Hazes JM, Lamberts SW, van Rossum EF, et al. Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol. 2013;9(11):670\u201386.","journal-title":"Nat Rev Endocrinol."},{"issue":"5","key":"334_CR25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","volume":"25","author":"JW Tomlinson","year":"2004","unstructured":"Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 2004;25(5):831\u201366.","journal-title":"Endocr Rev"},{"issue":"24","key":"334_CR26","doi-asserted-by":"crossref","first-page":"E2482","DOI":"10.1073\/pnas.1323681111","volume":"111","author":"SA Morgan","year":"2014","unstructured":"Morgan SA, McCabe EL, Gathercole LL, Hassan-Smith ZK, Larner DP, Bujalska IJ, et al. 11beta-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci USA. 2014;111(24):E2482\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"334_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1472-6823-14-71","volume":"14","author":"NC Nicolaides","year":"2014","unstructured":"Nicolaides NC, Charmandari E, Chrousos GP, Kino T. Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. BMC Endocr Disord. 2014;14:71.","journal-title":"BMC Endocr Disord."},{"issue":"6 Pt 2","key":"334_CR28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0022-3476(87)80050-1","volume":"111","author":"JR Salaman","year":"1987","unstructured":"Salaman JR, Gomes Da Costa CA, Griffin PJ. Renal transplantation without steroids. J Pediatr. 1987;111(6 Pt 2):1026\u20138.","journal-title":"J Pediatr."},{"issue":"4","key":"334_CR29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00007890-198704000-00010","volume":"43","author":"PJ Griffin","year":"1987","unstructured":"Griffin PJ, Da Costa CA, Salaman JR. A controlled trial of steroids in cyclosporine-treated renal transplant recipients. Transplantation. 1987;43(4):505\u20138.","journal-title":"Transplantation"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0334-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-015-0334-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0334-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T22:51:13Z","timestamp":1567205473000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-015-0334-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,24]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1007\/s40261-015-0334-2","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,24]]}}}